Tag: <span>COVID-19 treatment patent</span>

Home / COVID-19 treatment patent
RedHill’s oral broad-acting antiviral, Opaganib, granted new COVID-19 treatment patent
Post

RedHill’s oral broad-acting antiviral, Opaganib, granted new COVID-19 treatment patent

REDHILL BIOPHARMA CREDIT: REDHILL BIOPHARMA TEL AVIV, Israel and RALEIGH, NC, October 19, 2022, RedHill Biopharma Ltd. (Nasdaq: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company, today announced the granting by the United States Patent and Trademark Office (USPTO) of a further method of use patent that protects the administration of opaganib for the...